Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) is projected to release its Q2 2026 results before the market opens on Wednesday, August 12th. Analysts expect Acrivon Therapeutics to announce earnings of ($0.49) per share and revenue of $0.3860 million for the quarter. Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) last announced its quarterly earnings results on Wednesday, May 13th. On average, analysts expect Acrivon Therapeutics to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year. Get Acrivon Therapeutics alerts:Acrivon Therapeutics Stock PerformanceShares of Acrivon Therapeutics stock opened at $1.56 on Wednesday.